Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
about
Understanding Metabolomics in Biomedical ResearchAchieving Metabolic Flux Analysis for S. cerevisiae at a Genome-Scale: Challenges, Requirements, and ConsiderationsAnalysis of bacterial biofilms using NMR-based metabolomicsReview: toxicometabolomicsIncreased plasma citrulline in mice marks diet-induced obesity and may predict the development of the metabolic syndromeIdentification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancerSystemic perturbations of key metabolites in diabetic rats during the evolution of diabetes studied by urine metabonomicsMetabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological settingCombining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects.(1)H NMR-based metabolic profiling reveals inherent biological variation in yeast and nematode model systems.Metabolic Investigations of the Molecular Mechanisms Associated with Parkinson's DiseaseMetabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus.Biochemical characterization and 1H NMR based metabolomics revealed Melicope lunu-ankenda leaf extract a potent anti-diabetic agent in rats.Navigating the human metabolome for biomarker identification and design of pharmaceutical molecules.Metabolomic analyses for atherosclerosis, diabetes, and obesity.Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus.Glyoxylate, a new marker metabolite of type 2 diabetes.Metabolic consequences of sepsis-induced acute lung injury revealed by plasma ¹H-nuclear magnetic resonance quantitative metabolomics and computational analysisBrain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.High insulin combined with essential amino acids stimulates skeletal muscle mitochondrial protein synthesis while decreasing insulin sensitivity in healthy humans.Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitusDiabetes Associated Metabolomic Perturbations in NOD Mice.Metabonomic study of biochemical changes in urinary of type 2 diabetes mellitus patients after the treatment of sulfonylurea antidiabetic drugs based on ultra-performance liquid chromatography/mass spectrometry.Altered behavioral and metabolic circadian rhythms in mice with disrupted NAD+ oscillation.Metabolomic method: UPLC-q-ToF polar and non-polar metabolites in the healthy rat cerebellum using an in-vial dual extractionThe emerging field of quantitative blood metabolomics for biomarker discovery in critical illnessesEmerging applications of metabolomic and genomic profiling in diabetic clinical medicine.Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes.Effect of insulin sensitizer therapy on amino acids and their metabolites.Dynamic phosphometabolomic profiling of human tissues and transgenic models by 18O-assisted ³¹P NMR and mass spectrometryElevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.Metabolic Profiling of Total Physical Activity and Sedentary Behavior in Community-Dwelling Men.A mass spectrometric study for comparative analysis and evaluation of metabolite recovery from plasma by various solvent systems.System-wide assembly of pathways and modules hierarchically reveal metabolic mechanism of cerebral ischemiaInsulin fails to enhance mTOR phosphorylation, mitochondrial protein synthesis, and ATP production in human skeletal muscle without amino acid replacement.Mechanism by Which Caloric Restriction Improves Insulin Sensitivity in Sedentary Obese Adults.Assessment of old and new proteins: a novel methodology.Clinical metabolomics paves the way towards future healthcare strategies.Impact of Long-Term Poor and Good Glycemic Control on Metabolomics Alterations in Type 1 Diabetic People
P2860
Q26775206-DEDD35E4-84F0-428E-98A3-43535F4BDB7EQ26782197-78079854-169A-4071-877F-46A62667B5BCQ26851303-AA660DB7-2702-47AB-AF18-BDE46A3BD93CQ27001191-797EF77D-9990-4D9B-A360-5AC6DEEECD11Q28382948-986DC8EF-AE18-4489-8E81-D4D44CCF1D1DQ28478197-3A725FBB-1A10-4287-9719-7A33673DE600Q28485956-61B9CE82-C365-4A4C-95DF-A2C056DC3E80Q28748492-6115FEF7-6A1F-4C73-B930-C8CCA8066838Q33745104-02C5970F-6D55-448F-9691-74CE9BE9EEE2Q33746846-3A78D6F8-9591-4182-BCC5-5277825B937CQ33829694-2FD2B81C-4F30-428D-BDFF-711F6957B357Q33844949-68B7961A-2BD5-416F-A452-719F472236F1Q33854354-3D6A59EA-55E8-4BB4-8768-3293B2C36F9AQ33892872-45638770-73FE-4AA9-815D-931491C8D757Q34170091-4BC09F3B-382C-4C9C-A83C-EBC351683FB4Q34256164-BB74A67F-D165-447A-A4E0-86804E2B9906Q34336580-6C70214A-7151-4B43-8FE3-F1B6F2EE6629Q34454800-A7AE8DD4-60A4-4EF2-88A5-C7319C348774Q34502201-58023370-B636-4648-B4F9-FD78E481E107Q34624088-2A17E96D-DAC8-4569-93A1-3897A4BE7FE8Q34628283-023D6AF2-B017-4E67-B0A0-ECB8E76801EDQ35010970-B04ED779-2998-4D5F-910C-B347839D4381Q35153961-70977C4A-664C-4640-BE6E-3C67CAF9FFC7Q35180301-3B4B4951-9F65-4099-A94D-7069BAD5CFBDQ35254830-D83D2009-F111-46FB-8532-86650A55C02BQ35325389-C4C88E92-13EC-4F27-9A8A-9DB16FCAAFACQ35527861-98EAF9F9-DF5B-4787-AD27-38DAFCA5E148Q35563714-B1C59FAF-8A06-4CED-8974-C4551483A33DQ35902885-4849CD11-D81C-4853-9BDB-82D3AC0E798DQ35918756-85C81E27-40E0-40FD-AA78-C63F6C03604CQ35921213-B5BF1E38-DDD4-4180-B009-ADDC59BEBA99Q36043383-F4B30003-EC09-4049-90E8-FE962750ED2FQ36163882-27B8A3C1-356D-4015-98AA-289AB4307DE4Q36221553-B6C64F52-2592-48F6-93A4-13B54CC1B985Q36333298-B012FBCC-B7B5-41F2-A000-C6FECC9A59AEQ36382522-92B458D7-0919-4307-9985-7FDBBBAC4FA2Q36392864-8C518F3B-9029-4176-A2D6-2AC1AFEF5D42Q36511103-29F612E0-AB23-46E7-9D1A-B33A7157B2A8Q36620171-00299D69-2961-46DD-9B0E-7DD582A77FB6Q36716070-3F28FDBC-19F0-473F-B06E-A6936EB1A58B
P2860
Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Quantitative metabolomics by H ...... metabolic pathways in diabetes
@ast
Quantitative metabolomics by H ...... metabolic pathways in diabetes
@en
type
label
Quantitative metabolomics by H ...... metabolic pathways in diabetes
@ast
Quantitative metabolomics by H ...... metabolic pathways in diabetes
@en
prefLabel
Quantitative metabolomics by H ...... metabolic pathways in diabetes
@ast
Quantitative metabolomics by H ...... metabolic pathways in diabetes
@en
P2093
P2860
P1433
P1476
Quantitative metabolomics by H ...... metabolic pathways in diabetes
@en
P2093
Daniel Raftery
Helen Karakelides
Ian R Lanza
K Sreekumaran Nair
Lawrence E Ward
Shucha Zhang
P2860
P304
P356
10.1371/JOURNAL.PONE.0010538
P407
P577
2010-05-10T00:00:00Z